Pacific Biosciences of California PACB Europe, Middle East and Africa — Total Revenue
Other geography segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Pacific Biosciences of California in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.
The official record: Pacific Biosciences of California’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pacific Biosciences of California's europe, middle east and africa — total revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pacific Biosciences of California's europe, middle east and africa — total revenue?
- Pacific Biosciences of California (PACB) reported europe, middle east and africa — total revenue of $10.77M in Q1 2026.
- How has Pacific Biosciences of California's europe, middle east and africa — total revenue changed year-over-year?
- Pacific Biosciences of California's europe, middle east and africa — total revenue increased by 16.5% year-over-year, from $9.24M to $10.77M.
- What is the long-term trend for Pacific Biosciences of California's europe, middle east and africa — total revenue?
- Over 3 years (2022 to 2025), Pacific Biosciences of California's europe, middle east and africa — total revenue has grown at a 24.9% compound annual growth rate (CAGR), from $22.6M to $44.05M.
- What does europe, middle east and africa — total revenue mean?
- This metric represents the total revenue generated from the sale of genetic sequencing platforms, consumables, and related services within the Europe, Middle East, and Africa geographic region. It serves as a key indicator of the company's market penetration and adoption rates for its genomic analysis technologies in these specific international markets. Monitoring this figure helps investors assess the company's global footprint and the effectiveness of its regional sales and distribution strategies.